Figure 6.
(A) Intestinal immune system modulating activity of subfractions of F-3-related fractions prepared from the formulation of SKT alone or from the combination of SKT with ASR and CC. Filled squares, 10 µg/ml; open squares, 100 µg/ml. *P < 0.05 versus control. (B) Dose-dependent intestinal immune system modulating activity of F-3-1 from Fig. 5. Open circles, F-3-1 from SKT; filled squares, F-3-1 from SKT with ASR and CC. *P < 0.005 versus data of F-3-1 from SKT.